Gadolinium,[10-[2-(hydroxy-kO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]- cas no:120066-54-8
Synonyms: Gadolinium,[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7,O10]-;1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-(2-hydroxypropyl)-,gadolinium complex;(10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato)gadolinium;Gadolinium-HP-DO 3A;ProHance;SQ 32692;
NameGadolinium,[10-[2-(hydroxy-kO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-
CAS120066-54-8
SynonymsGadolinium,[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7,O10]-;1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-(2-hydroxypropyl)-,gadolinium complex;(10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato)gadolinium;Gadolinium-HP-DO 3A;ProHance;SQ 32692;
Molecular FormulaC17H29GdN4O7
Molecular Weight558.68
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| dog |
LD50 |
intravenous |
> 2800mg/kg (2800mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 36, Pg. 1409, 1994. |
| mouse |
LD50 |
intravenous |
6146mg/kg (6146mg/kg) |
|
Drugs of the Future. Vol. 17, Pg. 187, 1992. |
| rat |
LD |
intravenous |
> 5587mg/kg (5587mg/kg) |
|
Drugs of the Future. Vol. 17, Pg. 187, 1992. |
